Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHOENIX -- For ...

J&J wins FDA approval for TRUFILL system to treat chronic subdural hematoma via middle meningeal artery embolization.

A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, ...

The treatment of a subdural hematoma received a major boost with three new randomized controlled trials all showing large and significant benefits of a new embolization process done as an endovascular ...

A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, ...

- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - ...

New research by Society of Neurolnterventional Surgery (SNIS) members found that adjunctive middle meningeal artery embolization (MMAE) for the treatment of chronic subdural hematoma (CSDH) resulted ...

Society of NeuroInterventional Surgery says findings emphasize the need to update treatment protocols in the field FAIRFAX, Va. — New research by Society of Neurolnterventional Surgery (SNIS) members ...

IRVINE, Calif.--(BUSINESS WIRE)--Balt announced today that the first patients have been enrolled in the clinical trial; The Squid TM Trial for the Embolization of the Middle meningeal artery (STEM) ...

New AI algorithm enables precise and reliable labeling, visualization and quantification of subdural hemorrhage to make accurate and timely treatment decisions Viz.ai, the leader in AI-powered disease ...